Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Hunan Warrant Pharmaceutical Co Ltd
SSE:688799
Hunan Warrant Pharmaceutical Co Ltd
SSE:688799
Price:
57.21
CNY
1.1%
Market Closed
Market Cap:
¥7.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Hunan Warrant Pharmaceutical Co Ltd
SSE:688799
|
CN |
|
H
|
HL D&I Halla Corp
KRX:014790
|
KR |
|
CryptoStar Corp
XTSX:CSTR
|
CA |
|
L
|
London Stock Exchange Group PLC
SWB:LS4C
|
UK |
|
Frasers Logistics & Commercial Trust
SGX:BUOU
|
SG |
|
Genuine Parts Co
NYSE:GPC
|
US |
|
Styrenix Performance Materials Ltd
NSE:STYRENIX
|
IN |
|
U
|
UEM Edgenta Bhd
KLSE:EDGENTA
|
MY |
|
Lucara Diamond Corp
TSX:LUC
|
CA |
|
NVIDIA Corp
MIL:1NVDA
|
US |
|
JW Life Science Corp
KRX:234080
|
KR |
|
Aya Gold & Silver Inc
NASDAQ:AYA
|
CA |
|
N
|
Nexon Co Ltd
OTC:NEXOF
|
JP |
|
Daiwa House Industry Co Ltd
OTC:DWAHF
|
JP |
|
Mitsui O.S.K. Lines Ltd
TSE:9104
|
JP |
|
D
|
Delek US Holdings Inc
F:DEH
|
US |
|
Gouverneur Bancorp Inc
OTC:GOVB
|
US |
|
Promotora y Operadora de Infraestructura SAB de CV
F:AKY
|
MX |
|
Lotte Energy Materials Corp
KRX:020150
|
KR |
|
T
|
Touchstone International Medical Science Co Ltd
SSE:688013
|
CN |
|
Birkenstock Holding PLC
NYSE:BIRK
|
UK |
|
M
|
Mid-America Apartment Communities Inc
F:M2K
|
US |
|
Clinuvel Pharmaceuticals Ltd
F:UR9
|
AU |
|
Textron Inc
NYSE:TXT
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Hunan Warrant Pharmaceutical Co Ltd's stock price target?
Not Available
Hunan Warrant Pharmaceutical Co Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Hunan Warrant Pharmaceutical Co Ltd?
Projected CAGR
8%
8%
Over the last 6 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Hunan Warrant Pharmaceutical Co Ltd?
Projected CAGR
100%
100%
Over the last 6 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 1 year is 100%.
What is the Pre-Tax Income forecast for Hunan Warrant Pharmaceutical Co Ltd?
Projected CAGR
7%
7%
Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Hunan Warrant Pharmaceutical Co Ltd?
Projected CAGR
1%
1%
Over the last 6 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 3 years is 1%.